Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 761.58

+0.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1954)	10/28/2016 12:02:19 PM
From: Miljenko Zuanic	Read Replies (2) of 3559

Another bad news, potential delay in Sar BLA: secfilings.nasdaq.com This is bad by itself (delay of at least 3 months), so one can not "pound the table"! However, this is "REGULAR" (ROUTINE), not CMC/Pre-approval FDA inspection, so it may not be directly related to BLA deficiency and effect timing of approval. Nonetheless it is strange that they pot news out on 10/28, indicate low level expectation for BLA approval. Or excuse for something else??? Bad after bad, can this effect Dupilumab?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next